8 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... thrombosis; PE = pulmonary ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Ventilation-perfusion lung ... Rarely performed Anticoagulation ... and recurrent VTE ... pro-BNP levels • Risk ... Thromboendarterectomy #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE ... unless prior heart/lung ... medical and surgical management
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Spontaneous • Calf ... post-thrombotic syndrome ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... Risk Factors and ... Avoid Warfarin and DOAC ... suggest prophylactic anticoagulation ... Serial TTE and close
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... therapy - Second VTE ... Thromboembolism #Treatment #Algorithm ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #diagnosis #management